AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
Collegium Pharmaceutical
COLL
SilverCrest Metals
SILV
Enerpac Tool
EPAC
Halozyme Therapeutics
HALO
US Stock MarketDetailed Quotes
DVA DaVita
- 146.740
- +0.790+0.54%
Close Feb 27 16:00 ET
- 146.600
- -0.140-0.10%
Post 19:54 ET
11.74BMarket Cap13.68P/E (TTM)
147.990High145.410Low745.02KVolume146.620Open145.950Pre Close109.49MTurnover1.81%Turnover Ratio13.68P/E (Static)80.00MShares179.60052wk High96.92P/B6.06BFloat Cap124.78052wk Low--Dividend TTM41.26MShs Float179.600Historical High--Div YieldTTM1.77%Amplitude0.687Historical Low146.967Avg Price1Lot Size
DaVita News
DaVita Is Maintained at Equal-Weight by Barclays
DaVita Analyst Ratings
Barclays Maintains DaVita(DVA.US) With Hold Rating, Raises Target Price to $169
Analysts Are Neutral on Top Healthcare Stocks: DaVita (DVA), Exelixis (EXEL)
TD Cowen Maintains DaVita(DVA.US) With Hold Rating, Raises Target Price to $165
Analysts Offer Insights on Healthcare Companies: DaVita (DVA) and Charles River Labs (CRL)
Barclays Adjusts Price Target on DaVita to $169 From $164
Truist Financial Maintains DaVita(DVA.US) With Hold Rating
TD Cowen Sticks to Their Hold Rating for DaVita (DVA)
Bernstein Adjusts Price Target on DaVita to $184 From $161, Maintains Market Perform Rating
Truist Financial Maintains DaVita(DVA.US) With Hold Rating, Announces Target Price $170
Barclays Maintains DaVita(DVA.US) With Hold Rating, Maintains Target Price $164
TD Cowen Maintains DaVita(DVA.US) With Hold Rating, Maintains Target Price $150
TD Cowen Maintains DaVita(DVA.US) With Hold Rating, Maintains Target Price $150
DaVita Is Maintained at Equal-Weight by Barclays
DaVita Analyst Ratings
Barclays Maintains DaVita(DVA.US) With Hold Rating, Raises Target Price to $164
Truist Financial Maintains DaVita(DVA.US) With Hold Rating
BofA Securities Initiates DaVita(DVA.US) With Sell Rating, Announces Target Price $145
DaVita Analyst Ratings
